Vince Ippolito
Follow
Get notifications in MyBN when activity occurs.
Vince Ippolito
President, Executive Chair / Botanix Pharmaceuticals
Vince Ippolito has over 30 years of experience in the pharmaceuticals industry, including over 20 years in dermatology. He has been involved in the launch of more than 20 dermatology brands, and has held numerous executive roles including as executive vice president and chief commercial officer where he led two large dermatology M&A successes with combined valuations of US$7.8bn.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 91st | Botanix Pharmaceuticals | 100% | 43% |
| 866th | Mustera Property Group | -9% | -4% |
| 884th | Hazer Group | -10% | 17% |
| 1155th | BauMart Holdings | -29% | -19% |
| 1797th | RemSense Technologies | -75% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 132nd |  | Botanix Pharmaceuticals | $3.8m |
| 142nd | | Hazer Group | $2.4m |
| 143rd | | Mustera Property Group | $2.3m |
| 145th |  | RemSense Technologies | $2.2m |
| 146th | | BauMart Holdings | $2.2m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEWS: Tagged in Botanix taps investors for $13.5m | 27 Nov 2023 |
| NEWS: Tagged in Botanix secures $12.5m placement | 21 Jul 2023 |
| NEWS: Tagged in Incentives drive executive pay | 02 Dec 2020 |
| REMUNERATION UPDATE: President, Executive Chair, Botanix Pharmaceuticals | 02 Nov 2020 |
